February 10, 2020 4:22 pm
Published by Fluidda
In a recent article, the Food and Drug Administration (FDA) mentioned Fluidda’s FRI technology as an important tool to investigate regional drug deposition of the extrathoracic region, especially to measure... View Article
January 31, 2020 1:35 pm
Published by Fluidda
In a recent study, 10 patients with unstable, severe asthma were treated with Bronchial Thermoplasty (BT) of the left lung, while the right lung was used as an internal control. Changes in... View Article
January 27, 2020 12:13 pm
Published by Fluidda
High Frequency Chest Wall Oscillation (HFCWO) is a commonly used airway clearance technique for Cystic Fibrosis (CF) patients. At ERS 2019 in Madrid, a poster was presented on this topic.... View Article
January 10, 2020 3:58 pm
Published by Fluidda
Fluidda helps firefighters! Because of climate change, there is an increasing number of spontaneous wildfires all over the world, as we are now unfortunately experiencing in Australia. Fluidda, the company... View Article
January 8, 2020 11:00 am
Published by Fluidda
At the ERS 2019 conference in Madrid, our Director of Research and Development of Fluidda, gave his opinion on how Artificial Intelligence can help to improve the prediction of respiratory... View Article
December 20, 2019 4:09 pm
Published by Fluidda
Fluidda wishes you happy holidays and an inspiring 2020!
December 17, 2019 9:00 am
Published by Fluidda
At the University of Antwerp, Maarten Lanclus, Research & Development director of Fluidda, successfully defended his thesis on the topic of using Artificial Intelligence (A.I.) in combination with FRI to enhance... View Article
December 10, 2019 9:00 am
Published by Fluidda
At ERS 2019, Cedric van Holsbeke, Chief Technology Officer of Fluidda talks about Fluidda’s corporate responsibility project. Laptops, previously used for patient training purposes and training of clinical sites, have been donated by... View Article
December 6, 2019 11:38 am
Published by Fluidda
The Drug Delivery to the Lungs (DDL) Conference provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation. Fluidda is actively involved in... View Article
December 4, 2019 9:00 am
Published by Fluidda
During the ERS 2019 two posters were presented on the deposition of extrafine vs. non-extrafine formulations of different respiratory drugs in different inhalation devices. Both studies were conducted with Functional... View Article